Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHIL Evaluation in the Endovascular Treatment of Intracranial Cerebral ArterioVenous Malformation a European Multi-center, Observational, Prospective, Single Arm and Open Label Study

NCT03341039 is registered in ClinicalTrials.gov with Microvention-Terumo, Inc. as lead sponsor.

NCT NCT03341039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03341039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHIL Evaluation in the Endovascular Treatment of Intracranial Cerebral ArterioVenous Malformation a European Multi-center, Observational, Prospective, Single Arm and Open Label Study
Lead sponsor
Microvention-Terumo, Inc.
Phase
Observational
Overall status
Terminated
Start date
November 14, 2017
Completion date
October 14, 2020
Enrollment
20 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral av malformation